Skip to content

Megha M Vasavada

5 papers in the library · 243 citations · publishing 2016-2022

Papers

Sort Most recent Most cited

Modulation of the functional connectome in major depressive disorder by ketamine therapy.

Psychological Medicine October 1, 2022 Ashish K Sahib, Joana R Loureiro, Megha M Vasavada et al. 36 citations

Subanesthetic ketamine infusion therapy can produce fast-acting antidepressant effects in patients with major depression. How single and repeated ketamine treatment modulates the whole-brain functional connectome to affect clinical outcomes remains uncharacterized. Data-driven whole brain functional connectivity (FC) analysis was used to identify the functional connections modified by ketamine...

Depression treatment response to ketamine: sex-specific role of interleukin-8, but not other inflammatory markers

Translational Psychiatry March 21, 2021 Jennifer L. Kruse, Megha M Vasavada, Richard Olmstead et al. 47 citations

Abstract Inflammation plays a role in depression pathophysiology and treatment response, with effects varying by sex and therapeutic modality. Lower levels of interleukin(IL)-8 predict depression response to antidepressant medication and to electroconvulsive therapy (ECT), although ECT effects are specific to females. Whether IL-8 predicts depression response to ketamine and in a sex-specific...

Modulation of inhibitory control networks relate to clinical response following ketamine therapy in major depression.

Translational Psychiatry July 30, 2020 Ashish K Sahib, Joana Ra Loureiro, Megha M Vasavada et al. 37 citations

Subanesthetic ketamine is found to induce fast-acting and pronounced antidepressant effects, even in treatment resistant depression (TRD). However, it remains unclear how ketamine modulates neural function at the brain systems-level to regulate emotion and behavior. Here, we examined treatment-related changes in the inhibitory control network after single and repeated ketamine therapy in TRD....

Modulation of amygdala reactivity following rapidly acting interventions for major depression.

Human Brain Mapping May 1, 2020 Joana R Loureiro, Amber M Leaver, Megha M Vasavada et al. 65 citations

Electroconvulsive therapy (ECT) and ketamine treatment both induce rapidly acting antidepressant effects in patients with major depressive disorder unresponsive to standard treatments, yet their specific impact on emotion processing is unknown. Here, we examined the neural underpinnings of emotion processing within and across patients (N = 44) receiving either ECT (N = 17, mean age: 36.8, 11.0...

Structural connectivity and response to ketamine therapy in major depression: A preliminary study.

Journal of Affective Disorders January 15, 2016 Megha M Vasavada, Amber M Leaver, Randall Espinoza et al. 58 citations

Ketamine elicits an acute antidepressant effect in patients with major depressive disorder (MDD). Here, we used diffusion imaging to explore whether regional differences in white matter microstructure prior to treatment may predict clinical response 24h following ketamine infusion in 10 MDD patients. FSL's Tract-Based Spatial Statistics (TBSS) established voxel-level differences in fractional...